Literature DB >> 34405247

Prognostic Relevance of Pretreatment Peripheral Neutrophil Count and Neutrophil-to-lymphocyte Ratio in Primary Cutaneous Angiosarcoma.

Kentaro Awaji1, Takuya Miyagawa, Jun Omatsu, Hiroko Numajiri, Toru Kawai, Kaoru Funamizu, Ryosuke Saigusa, Daisuke Yamada, Yoshihide Asano, Shinichi Sato.   

Abstract

Systemic inflammatory response markers, including neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and monocyte-to-lymphocyte ratio, are useful prognostic factors for various malignant tumours. The aim of this study was to investigate the clinical relevance of these markers in primary cutaneous angiosarcoma. Twenty-six patients were retrospectively divided into 2 groups according to pretreatment peri-pheral blood cell counts or systemic inflammatory response marker levels; overall survival and progression-free survival were compared. Univariate analysis found that high neutrophil count (> 3.1×109/l), high neutrophil-to-lymphocyte ratio (> 2.4), high platelet-to-lymphocyte ratio (> 175) and low lymphocyte count (≤ 1.3×109/l) were related to shorter overall survival, while high neutrophil and low lymphocyte groups had shorter progression-free survival. In multivariate analysis, high neutrophil count and high neutrophil-to- lymphocyte ratio (hazard ratio 7.44 and 5.04, 95% confidence interval 1.48-37.2 and 1.26-20.1, respectiv-ely) were identified as independent prognostic factors for poor overall survival. These results indicate that systemic inflammatory response markers serve as prognostic predictors in primary cutaneous angiosarcoma, as well as in other types of soft-tissue sarcoma.

Entities:  

Keywords:  neutrophil, neutrophil-to-lymphocyte ratio; overall survival; prognostic factor; systemic inflammatory response; cutaneous angiosarcoma

Mesh:

Year:  2021        PMID: 34405247      PMCID: PMC9413664          DOI: 10.2340/00015555-3898

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  27 in total

Review 1.  Angiosarcoma.

Authors:  Robin J Young; Nicola J Brown; Malcolm W Reed; David Hughes; Penella J Woll
Journal:  Lancet Oncol       Date:  2010-05-25       Impact factor: 41.316

2.  Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.

Authors:  Bo Hu; Xin-Rong Yang; Yang Xu; Yun-Fan Sun; Chao Sun; Wei Guo; Xin Zhang; Wei-Min Wang; Shuang-Jian Qiu; Jian Zhou; Jia Fan
Journal:  Clin Cancer Res       Date:  2014-09-30       Impact factor: 12.531

Review 3.  The role of platelets in the tumor microenvironment: From solid tumors to leukemia.

Authors:  MengJie Yan; Paul Jurasz
Journal:  Biochim Biophys Acta       Date:  2015-07-17

4.  Systemic Immune-inflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung Cancer.

Authors:  Xuan Hong; Baohong Cui; Meng Wang; Zhaoyang Yang; Li Wang; Qingyong Xu
Journal:  Tohoku J Exp Med       Date:  2015-08       Impact factor: 1.848

5.  The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.

Authors:  Kai Wang; Tiansheng Shen; Gene P Siegal; Shi Wei
Journal:  Hum Pathol       Date:  2017-10-06       Impact factor: 3.466

6.  Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity.

Authors:  C T McGary; M E Miele; D R Welch
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

7.  Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects.

Authors:  Basem Azab; Marlene Camacho-Rivera; Emanuela Taioli
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

8.  The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Xuemin Wang; Shiqiang Su; Yuanshan Guo
Journal:  Oncotarget       Date:  2017-09-20

9.  The prognostic value of pretreatment inflammatory biomarkers in primary angiosarcoma.

Authors:  Manni Wang; Shuang Wu; An Tong; Xiwei Cui; Xuelei Ma
Journal:  Cancer Manag Res       Date:  2019-08-22       Impact factor: 3.989

10.  Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis.

Authors:  Ruonan Yang; Qian Chang; Xianchun Meng; Nan Gao; Wanhai Wang
Journal:  J Cancer       Date:  2018-09-07       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.